By Karen Roman Imviva Biotech said it is presenting two findings associated with relapsed or...

By Karen Roman Imviva Biotech said the FDA cleared its Investigational New Drug application for...

By Karen Roman VERAXA Biotech AG said it has a securities purchase agreement with an...

By Daniella Parra Imviva Biotech said data showed its CTA313 drug resulted in 50% of...

By Daniella Parra SkylineDx shared new findings in cutaneous squamous cell carcinoma (CSCC) research that...

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the recent outbreak of the hantavirus on...

By Daniella Parra Glucotrack, Inc. (Nasdaq: GCTK) said it has submitted an Investigational Device Exemption...

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the FDA granted “Orphan Drug Designation” (ODD)...

By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it designated Michael Buckner as Chief...

By Daniella Parra Glucotrack, Inc. (Nasdaq: GCTK) shared a study highlighting the long-term accuracy of...